|
|
Volumn 45, Issue S5, 2013, Pages
|
|
Practical insights into enhanced management of patients with HCV infection with direct antiviral agents
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BOCEPREVIR;
INTERLEUKIN 28B;
TELAPREVIR;
COST UTILITY ANALYSIS;
DNA POLYMORPHISM;
DRUG SAFETY;
EDITORIAL;
HEALTH CARE ACCESS;
HEPATITIS C;
HEPATITIS C VIRUS;
HUMAN;
LIVER CELL CARCINOMA;
LIVER CIRRHOSIS;
LIVER FIBROSIS;
LIVER TRANSPLANTATION;
MORTALITY;
NONHODGKIN LYMPHOMA;
PRIORITY JOURNAL;
TREATMENT OUTCOME;
ANTIVIRAL AGENTS;
GENOTYPE;
HEPACIVIRUS;
HEPATITIS C;
HUMANS;
|
|
EID: 84884727966
PISSN: 15908658
EISSN: 18783562
Source Type: Journal
DOI: 10.1016/j.dld.2013.08.001 Document Type: Editorial |
|
Times cited : (1)
|
|
References (0)
|
